Atlas Trials

Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

Clinical trial NCT07532096 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07532096
Sponsor
Xijing Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2026-04-25
Primary completion
2027-05-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.